Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Laura R  – Israel, 2020-03-22 08:58 (826 d 05:35 ago) – Posting: # 21294
Views: 2,978

Hi, was wondering how P1 CROs are dealing with the COVID19 crisis, and if there is any chance to keep studies moving (in small cohorts, no overnight stays, etc).
Should HV studies considered an essential activity per the new FDA/EMA guidances, is voluteering in a Phase 1 study considered a valid reason to be outside? Laura

Complete thread:

UA Flag
Activity
 Admin contact
22,170 posts in 4,645 threads, 1,570 registered users;
online 14 (0 registered, 14 guests [including 7 identified bots]).
Forum time: Sunday 15:34 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5